Patents by Inventor Danielle Nicole Turner

Danielle Nicole Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240010619
    Abstract: The present disclosure describes a method to treat conditions, including bacterial infections. The compounds of the disclosure can also interact synergistically with antibiotics used concomitantly to kill drug-resistant bacteria.
    Type: Application
    Filed: July 5, 2023
    Publication date: January 11, 2024
    Inventors: Danielle Nicole TURNER, Liliya FROLOVA, Alexander KORNIENKO, Snezna ROGELJ
  • Publication number: 20230310541
    Abstract: The present disclosure provides pharmaceutical compositions for treating fungal and bacterial infections. The pharmaceutical compositions of the disclosure comprise a cationic surfactant, a chelating agent, and at least one solvent. The pharmaceutical compositions of the disclosure can be used to treat drug-sensitive or multi drug-resistant bacterial or fungal infections.
    Type: Application
    Filed: November 29, 2022
    Publication date: October 5, 2023
    Inventors: Snezna ROGELJ, Danielle Nicole TURNER
  • Patent number: 11554157
    Abstract: The present disclosure provides pharmaceutical compositions for treating fungal and bacterial infections. The pharmaceutical compositions of the disclosure comprise a cationic surfactant, a chelating agent, and at least one solvent. The pharmaceutical compositions of the disclosure can be used to treat drug-sensitive or multi drug-resistant bacterial or fungal infections.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: January 17, 2023
    Assignee: NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION
    Inventors: Snezna Rogelj, Danielle Nicole Turner
  • Publication number: 20210386707
    Abstract: The present disclosure describes a method of treating an infection, including a parasitic infection, using compounds of the invention. The compounds of the invention can selectively eradicate intracellular mammalian and human parasites.
    Type: Application
    Filed: October 29, 2019
    Publication date: December 16, 2021
    Inventors: Snezna ROGELJ, Danielle Nicole Turner, Ivy Hurwitz, Alexander Aksenov
  • Publication number: 20210361737
    Abstract: The present disclosure provides pharmaceutical compositions for treating fungal and bacterial infections. The pharmaceutical compositions of the disclosure comprise a cationic surfactant, a chelating agent, and at least one solvent. The pharmaceutical compositions of the disclosure can be used to treat drug-sensitive or multi drug-resistant bacterial or fungal infections.
    Type: Application
    Filed: April 11, 2019
    Publication date: November 25, 2021
    Inventors: Snezna ROGELJ, Danielle Nicole TURNER
  • Publication number: 20190337893
    Abstract: The present disclosure describes a method to treat conditions, including bacterial infections and cancer, using a photosensitive compound that, upon exposure to white light, can be activated. The photosensitive compound can also interact synergistically with antibiotics used concomitantly to kill drug-resistant bacteria. The photosensitive compounds can also be used to inhibit the proliferation of cancer cells.
    Type: Application
    Filed: February 4, 2019
    Publication date: November 7, 2019
    Inventors: Snezna ROGELJ, Liliya FROLOVA, Alexander KORNIENKO, Leslie D. EDWARDS, Cody CHAMPION, Kailee ZINGLER, Danielle Nicole Turner
  • Patent number: 10239834
    Abstract: The present disclosure describes a method to treat conditions, including bacterial infections and cancer, using a photosensitive compound that, upon exposure to white light, can be activated. The photosensitive compound can also interact synergistically with antibiotics used concomitantly to kill drug-resistant bacteria. The photosensitive compounds can also be used to inhibit the proliferation of cancer cells.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: March 26, 2019
    Assignee: NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION
    Inventors: Snezna Rogelj, Liliya Frolova, Alexander Kornienko, Leslie D. Edwards, Cody Champion, Kailee Zingler, Danielle Nicole Turner
  • Publication number: 20180155286
    Abstract: The present disclosure describes a method to treat conditions, including bacterial infections and cancer, using a photosensitive compound that, upon exposure to white light, can be activated. The photosensitive compound can also interact synergistically with antibiotics used concomitantly to kill drug-resistant bacteria. The photosensitive compounds can also be used to inhibit the proliferation of cancer cells.
    Type: Application
    Filed: October 31, 2017
    Publication date: June 7, 2018
    Inventors: Snezna ROGELJ, Liliya FROLOVA, Alexander KORNIENKO, Leslie D. EDWARDS, Cody CHAMPION, Kailee ZINGLER, Danielle Nicole Turner
  • Patent number: 9834514
    Abstract: The present disclosure describes a method to treat conditions, including bacterial infections and cancer, using a photosensitive compound that, upon exposure to white light, can be activated. The photosensitive compound can also interact synergistically with antibiotics used concomitantly to kill drug-resistant bacteria. The photosensitive compounds can also be used to inhibit the proliferation of cancer cells.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: December 5, 2017
    Assignee: NEW MEXICO TECH RESEARCH FOUNDATION
    Inventors: Snezna Rogelj, Liliya Frolova, Alexander Kornienko, Leslie D. Edwards, Cody Champion, Kailee Zingler, Danielle Nicole Turner